Abstract |
In the monotherapeutic treatment of an acute schizophrenic psychoses with butyrophenones ( haloperidol and benperidol) we saw immediate leucopenic reactions when the medication was given every day. In literature the risk of butyrophenone-induced blood dyscrasias seems to be underestimated. Therefore we decided to report this single case evaluation. When benperidol (short elimination--half life period) was given every other day ("interval- therapy") the blood cell count of the leucocytes normalized. Furthermore, the amount of psychopathological abnormalities measured by the Brief Psychiatric Rating Scale decreased under this intermittent treatment.
|
Authors | M Grube, A Kurzweg |
Journal | Der Nervenarzt
(Nervenarzt)
Vol. 70
Issue 9
Pg. 838-41
(Sep 1999)
ISSN: 0028-2804 [Print] Germany |
Vernacular Title | Leukopenie unter Butyrophenonen. Erfolgreiche Psychosebehandlung durch Neuroleptika-Intervallverabreichung. |
PMID | 10522254
(Publication Type: Case Reports, English Abstract, Journal Article)
|
Chemical References |
- Antipsychotic Agents
- Benperidol
- Haloperidol
|
Topics |
- Antipsychotic Agents
(administration & dosage, adverse effects)
- Benperidol
(administration & dosage, adverse effects)
- Female
- Haloperidol
(administration & dosage, adverse effects)
- Humans
- Leukopenia
(chemically induced, prevention & control)
- Middle Aged
- Pulse Therapy, Drug
- Schizophrenia
(blood, drug therapy)
- Treatment Outcome
|